• Mashup Score: 69

    Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases (NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also regress liver disease. Weight reductions of ⩾10% can induce a near universal non-alcoholic steatohepatitis resolution and fibrosis improvement by at least one stage. However, modest weight loss (>5%) can also produce…

    Tweet Tweets with this article
    • RT @drkeithsiau: Impact of weight loss on NAFLD #LiverTwitter #4KMedEd https://t.co/1KkikVanfm https://t.co/n5GqLWX1eo

  • Mashup Score: 3

    To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD – defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different…

    Tweet Tweets with this article
    • Reading the Baveno VII consensus document https://t.co/CwEncLCc8k "In patients presenting w/acute variceal bleeding, rapid removal of blood from the GI tract (lactulose PO/enemas) should be used to prevent hepatic encephalopathy" Do you routinely follow this? 👆 #livertwitter

  • Mashup Score: 180

    Portal hypertension is a major consequence of cirrhosis and is responsible for its most severe complications, including ascites, bleeding from gastroesophageal varices and encephalopathy. The evaluation of diagnostic tools and the design and conduct of high-quality clinical trials for the treatment of portal hypertension and its complications have always been difficult. Awareness of these…

    Tweet Tweets with this article
    • RT @drkeithsiau: Guidelines on variceal bleeding - fresh off the press from Baveno VII 🩸🆕 https://t.co/Jryanh4s1n https://t.co/hhCvPLam0X

  • Mashup Score: 58

    Hepatopulmonary syndrome (HPS) is the most common cause of respiratory insufficiency in patients with chronic liver disease. It is characterised by a gas exchange abnormality caused by intrapulmonary vascular dilatations (IPVD) in patients with liver diseases. It occurs in 5–32% of liver transplant candidates.1 Abnormal oxygenation is defined by elevated alveolar-arterial oxygen gradient…

    Tweet Tweets with this article
    • RT @drkeithsiau: Hepatopulmonary syndrome #LiverTwitter #4KMedEd (Via @JHepatology) https://t.co/dSNoGrWIyG https://t.co/rnGthKM0UO

  • Mashup Score: 0

    Alpha-1 antitrypsin deficiency (AATD) arises from mutations in the SERPINA1 gene encoding alpha-1 antitrypsin (AAT) that lead to AAT retention in the endoplasmic reticulum of hepatocytes, causing proteotoxic liver injury and loss-of-function lung disease. The homozygous Pi*Z mutation (Pi*ZZ genotype) is responsible for the majority of severe AATD cases and can precipitate both pediatric and adult…

    Tweet Tweets with this article
    • Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder - Journal of Hepatology https://t.co/8yT2GT4b6Y